DIPLOMAT PHARMACY INC's ticker is DPLO and the CUSIP is 25456K101. A total of 156 filers reported holding DIPLOMAT PHARMACY INC in Q4 2015. The put-call ratio across all filers is 0.44 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $296,000 | -65.5% | 74,070 | -57.6% | 0.00% | – |
| Q3 2019 | $857,000 | -67.1% | 174,648 | -59.2% | 0.00% | – |
| Q2 2019 | $2,608,000 | +106.7% | 428,317 | +97.1% | 0.00% | – |
| Q1 2019 | $1,262,000 | +118.3% | 217,300 | +405.3% | 0.00% | – |
| Q4 2018 | $578,000 | +78.4% | 43,000 | +157.5% | 0.00% | – |
| Q3 2018 | $324,000 | -85.4% | 16,700 | -80.8% | 0.00% | – |
| Q2 2018 | $2,221,000 | +49.4% | 86,900 | +17.8% | 0.00% | – |
| Q1 2018 | $1,487,000 | +7.2% | 73,800 | +6.8% | 0.00% | – |
| Q4 2017 | $1,387,000 | -40.4% | 69,100 | -38.6% | 0.00% | -100.0% |
| Q3 2017 | $2,329,000 | +107.8% | 112,500 | +48.6% | 0.00% | – |
| Q2 2017 | $1,121,000 | +6.6% | 75,700 | +14.7% | 0.00% | – |
| Q1 2017 | $1,052,000 | -25.2% | 66,000 | -40.9% | 0.00% | – |
| Q4 2016 | $1,407,000 | -66.0% | 111,667 | -24.3% | 0.00% | -100.0% |
| Q3 2016 | $4,135,000 | +1.2% | 147,600 | +26.5% | 0.00% | 0.0% |
| Q2 2016 | $4,085,000 | +1.1% | 116,700 | -20.9% | 0.00% | 0.0% |
| Q1 2016 | $4,042,000 | +3.7% | 147,535 | +29.5% | 0.00% | +100.0% |
| Q4 2015 | $3,898,000 | +43.3% | 113,900 | +20.2% | 0.00% | – |
| Q3 2015 | $2,721,000 | -38.4% | 94,722 | -4.0% | 0.00% | -100.0% |
| Q2 2015 | $4,414,000 | +144.0% | 98,648 | +88.6% | 0.00% | +100.0% |
| Q1 2015 | $1,809,000 | +74.6% | 52,316 | +38.3% | 0.00% | – |
| Q4 2014 | $1,036,000 | – | 37,835 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|